Literature DB >> 18234637

Prognostic factors for chronic severe hepatitis and construction of a prognostic model.

Qian Li1, Gui-Yu Yuan, Ke-Cheng Tang, Guo-Wang Liu, Rui Wang, Wu-Kui Cao.   

Abstract

BACKGROUND: Chronic severe hepatitis is a serious illness with a high mortality rate. Discussion of prognostic judgment criteria for chronic severe hepatitis is of great value in clinical guidance. This study was designed to investigate the clinical and laboratory indices affecting the prognosis of chronic severe hepatitis and construct a prognostic model.
METHODS: The clinical and laboratory indices of 213 patients with chronic severe hepatitis within 24 hours after diagnosis were analyzed retrospectively. Death or survival was limited to within 3 months after diagnosis.
RESULTS: The mortality of all patients was 47.42%. Compared with the survival group, the age, basis of hepatocirrhosis, infection, degree of hepatic encephalopathy (HE) and the levels of total bilirubin (TBil), total cholesterol (CHO), cholinesterase (CHE), blood urea nitrogen (BUN), blood creatinine (Cr), blood sodium ion (Na), peripheral blood leukocytes (WBC), alpha-fetoprotein (AFP), international normalized ratio (INR) of blood coagulation and prothrombin time (PT) were significantly different in the group who died, but the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin (ALB) and hemoglobin (HGB) were not different between the two groups. At the same time, a regression model, Logit (P) =1.573XAge+1.338XHE-1.608XCHO+0.011XCr-0.109XNa+1.298XINR+11.057, was constructed by logistic regression analysis and the prognostic value of the model was higher than that of the MELD score.
CONCLUSIONS: Multivariate analysis excels univariate analysis in the prognosis of chronic severe hepatitis, and the regression model is of significant value in the prognosis of this disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18234637

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  5 in total

1.  Combined MELD and blood lipid level in evaluating the prognosis of decompensated cirrhosis.

Authors:  Ming Jiang; Fei Liu; Wu-Jun Xiong; Lan Zhong; Wen Xu; Fei Xu; Yan-Bing Liu
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

2.  Differential proteomics analysis of liver failure in peripheral blood mononuclear cells using isobaric tags for relative and absolute quantitation.

Authors:  Hua Lin; Qiu-Pei Tan; Wei-Guo Sui; Wen-Biao Chen; Wu-Jian Peng; Xing-Chao Liu; Yong Dai
Journal:  Biomed Rep       Date:  2016-12-30

3.  Comparison of extracorporeal cellular therapy (ELAD®) vs standard of care in a randomized controlled clinical trial in treating Chinese subjects with acute-on-chronic liver failure.

Authors:  Zhongping Duan; Shaojie Xin; Jing Zhang; Shaoli You; Yu Chen; Hongling Liu; Sujun Zheng; Zheng Li; Robert Ashley; Michael Millis
Journal:  Hepat Med       Date:  2018-11-16

4.  Detection of telomerase reverse transcriptase mRNA in peripheral blood mononuclear cells of patients with liver failure.

Authors:  Zhu Chuanwu; Qian Feng; Li Ming; Wang Haiyan; Fang Huan; Luo Xiangrong; Zhang Xuehua; Zhu Xiang; Shen Xiujuan; Xu Ping
Journal:  Hepat Mon       Date:  2014-04-14       Impact factor: 0.660

5.  Prediction of survival after liver transplantation for chronic severe hepatitis B based on preoperative prognostic scores: a single center's experience in China.

Authors:  Liang Xiao; Zhi-Ren Fu; Guo-Shan Ding; Hong Fu; Zhi-Jia Ni; Zheng-Xin Wang; Xiao-Min Shi; Wen-Yuan Guo; Jun Ma
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.